• 1
    Moder KG. New medications for use in patients with rheumatoid arthritis. Ann Allergy Asthma Immunol 2000; 84: 2804.
  • 2
    Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 77899.
  • 3
    Alarcon GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 1995; 21: 589604.
  • 4
    Matteson EL. Current treatment strategies for rheumatoid arthritis. Mayo Clin Proc 2000; 75: 6974.
  • 5
    Schuna AA, Megeff C. New drugs for the treatment of rheumatoid arthritis. Am J Health Syst Pharm 2000; 57: 22534.
  • 6
    Fries JF. Safety, cost and effectiveness issues with disease modifying anti-rheumatic drugs in rheumatoid arthritis. Ann Rheum Dis 1999; 58 Suppl 1: I869.
  • 7
    Ramsburg KL. Rheumatoid arthritis. Am J Nurs 2000; 100: 403.
  • 8
    Vliet Vlieland TP, Hazes JM. Efficacy of mltidisciplinary team care programs in rheumatoid arthritis. Semin Arthritis Rheum 1997; 27: 11022.
  • 9
    Cochrane Effective Practice and Organization of Care Group (EPOC) Information page. The Cochrane Database of Systematic Reviews Web site. Accessed September 12, 2001. URL:
  • 10
    Subcommittee on Populations. National Committee on Vital and Health Statistics: Classifying and reporting functional status 2001. URL: Accessed April 19, 2002.
  • 11
    Hedges LV, Olkin I. Statistical methods for meta-analysis. Orlando (FL): Academic Press; 1985.
  • 12
    Cohen J. Statistical power analysis for the behavioral sciences. revised edition. New Jersey: Lawrence Erlbaum Associates; 1988.
  • 13
    Cohen J. Statistical power analysis for the behavior sciences. 2nd ed. New York: Academic Press; 1977.
  • 14
    Rosenthal R, Rubin D. Combining results from independent studies. Psychol Bull 1979; 85: 18593.
  • 15
    Glass G. Summarizing effect sizes. New directions for methodology of social and behavioral science: quantitative assessment of research domains. San Francisco: Jossey-Bass; 1980.
  • 16
    Rosenthal R. Meta-analytic procedures for social research. Beverly Hills (CA): Sage Publications; 1984.
  • 17
    Evidence Report and Evidence-Based Recommendations: interventions that increase the utilization of Medicare-funded preventive services for persons age 65 and older. Washington (DC): US Department of Health and Human Services, Health Care Financing Administration; 1999. Publication No. 02145
  • 18
    Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 62934.
  • 19
    Light RJ, Pillemer DB. Summing up: the science of reviewing research. Cambridge (MA): Harvard University Press; 1984.
  • 20
    Taal E, Riemsma RP, Brus HL, Seydel ER, Rasker JJ, Wiegman O. Group education for patients with rheumatoid arthritis. Patient Educ Couns 1993; 20: 17787.
  • 21
    Schned ES, Doyle MA, Glickstein SL, Schousboe JT, Reinertsen JL, Baglioni AJ, et al. Team managed outpatient care for early onset chronic inflammatory arthritis. J Rheumatol 1995; 22: 11418.
  • 22
    Ahlmen M, Sullivan M, Bjelle A. Team versus non-team outpatient care in rheumatoid arthritis: a comprehensive outcome evaluation including an overall health measure. Arthritis Rheum 1988; 31: 4719.
  • 23
    Katz S, Vignos PJJ, Moskowitz RW, Thompson HM, Svec KH. Comprehensive outpatient care in rheumatoid arthritis: a controlled study. JAMA 1968; 206: 124954.
  • 24
    Lindroth Y, Brattstrom M, Bellman I, Ekestaf G, Olofsson Y, Strombeck B, et al. A problem-based education program for patients with rheumatoid arthritis: evaluation after three and twelve months. Arthritis Care Res 1997; 10: 32532.
  • 25
    Parker JC, Singsen BH, Hewett JE, Walker SE, Hazelwood SE, Hall PJ, et al. Educating patients with rheumatoid arthritis: a prospective analysis. Arch Phys Med Rehabil 1984; 65: 7714.
  • 26
    Scholten C, Brodowicz T, Graninger W, Gardavsky I, Pils K, Pesau B, et al. Persistent functional and social benefit 5 years after a multidisciplinary arthritis training program. Arch Phys Med Rehabil 1999; 80: 12827.
  • 27
    Vliet Vlieland TP, Breedveld FC, Hazes JM. The two-year follow-up of a randomized comparison of in-patient multidisciplinary team care and routine out-patient care for active rheumatoid arthritis. Br J Rheumatol 1997; 36: 825.
  • 28
    Anderson RB, Needleman RD, Gatter RA, Andrews RP, Scarola JA. Patient outcome following inpatient vs outpatient treatment of rheumatoid arthritis. J Rheumatol 1988; 15: 55660.
  • 29
    Lindroth Y, Bauman A, Brooks PM, Priestley D. A 5-year follow-up of a controlled trial of an arthritis education programme. Br J Rheumatol 1995; 34: 64752.
  • 30
    Spiegel JS, Spiegel TM, Ward NB, Paulus HE, Leake B, Kane RL. Rehabilitation for rheumatoid arthritis patients: a controlled trial. Arthritis Rheum 1986; 29: 62837.
  • 31
    Goldsmith CH, Boers M, Bombardier C, Tugwell P, and the OMERACT Committee. Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. J Rheumatol 1993; 20: 5615.
  • 32
    Wells GA, Tugwell P, Kraag GR, Baker PR, Groh J, Redelmeier DA. Minimum important difference between patients with rheumatoid arthritis: the patient's perspective. J Rheumatol 1993; 20: 55760.
  • 33
    Superio-Cabuslay E, Ward MM, Lorig KR. Patient education interventions in osteoarthritis and rheumatoid arthritis: a meta-analytic comparison with nonsteroidal antiinflammatory drug treatment. Arthritis Care Res 1996; 9: 292301.
  • 34
    Mullen PD, Laville EA, Biddle AK, Lorig K. Efficacy of psychoeducational interventions on pain, depression, and disability in people with arthritis: a meta-analysis. J Rheumatol 1987; 14 Suppl 15: 339.
  • 35
    Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27 Suppl 3: S17889.
  • 36
    Ellrodt G, Cook DJ, Lee J, Cho M, Hunt D, Weingarten S. Evidence-based disease management. JAMA 1997; 278: 168792.